株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

再生医療の世界市場:市場規模・シェア・見通し・機会分析 - 組織タイプ・用途・エンドユーザー・地域別

Regenerative Therapies Market: By Tissue Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

発行 Coherent Market Insights 商品コード 931947
出版日 ページ情報 英文 171 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。
再生医療の世界市場:市場規模・シェア・見通し・機会分析 - 組織タイプ・用途・エンドユーザー・地域別 Regenerative Therapies Market: By Tissue Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日: 2020年04月02日 ページ情報: 英文 171 Pages
概要

再生医療は、最も急速に発展している医療分野のひとつです。整形外科における再生医療では、筋骨格系の細胞の再生を刺激することにより自然治癒を促進させます。組織工学および生物医学工学に関する標準ガイドラインの欠如や、市場参入の障壁となっている長期間の臨床試験が市場の成長を抑制すると考えられています。

当レポートでは、世界の再生医療市場を調査し、市場の概要、組織タイプ・用途・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と仮定

  • 調査目的
  • 仮定
  • 略語

第2章 市場展望

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • マーケットスニペット:組織タイプ別
    • マーケットスニペット:用途別
    • マーケットスニペット:エンドユーザー別
    • マーケットスニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学・規制・動向分析

  • 市場力学
    • 市場の成長要因
    • 市場の阻害要因
    • 市場機会
  • 影響分析
  • 主要動向
  • 規制シナリオ
  • PEST分析

第4章 世界の再生医療市場:組織タイプ別

  • イントロダクション
  • 同種移植
  • 異種移植
  • 人工材料移植

第5章 世界の再生医療市場:用途別

  • イントロダクション
  • 軟組織修復
  • 心血管
  • 歯科
  • 整形外科
  • 中枢神経疾患
  • その他

第6章 世界の再生医療市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 外来外科センター
  • 教育機関

第7章 世界の再生医療市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第8章 競合情勢

  • 企業プロファイル
    • Shire Pharmaceuticals
    • Kinetic Concepts, Inc.
    • Mesoblast Ltd.
    • Nuo Therapeutics (Cytomedix Inc.)
    • Advanced Cell Technology, Inc.
    • BioStem Life Sciences
    • Akron Biotechnology, LLC
    • Organovo Holdings Inc.
    • Orgenesis Inc.
    • Pluristem Therapeutics Inc.
    • Genzyme
    • Athersys, Inc.
    • RenovaCare, Inc.
    • Cytori Therapeutics, Inc.

第9章 セクション

  • 参考資料
  • 調査手法
  • Coherant Market Insightsについて
目次

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Regenerative Therapies Market, By Tissue Type:

Allograft

Xenograft

Alloplast

Global Regenerative Therapies Market, By Application:

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

Global Regenerative Therapies Market, By End User:

Hospitals

Ambulatory Surgical Centers

Educational Institutes

Global Regenerative Therapies Market, By Geography:

North America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.S.

Canada

Europe

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

GCC

Israel

Rest of Middle East

Africa

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Shire Pharmaceuticals *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Kinetic Concepts, Inc.

Mesoblast Ltd.

Nuo Therapeutics (Cytomedix Inc.)

Advanced Cell Technology, Inc.

BioStem Life Sciences

Akron Biotechnology, LLC

Organovo Holdings Inc.

Orgenesis Inc.

Pluristem Therapeutics Inc.

Genzyme

Athersys, Inc.

RenovaCare, Inc.

Cytori Therapeutics, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Tissue Type
  • Market Snippet, By Application
  • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Allograft
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Xenograft
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Alloplast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Regenerative Therapies Market, By Application, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Soft Tissue Repair
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • CNS disease treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Regenerative Therapies Market, By End User, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Educational Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Regenerative Therapies Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Shire Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kinetic Concepts, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mesoblast Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nuo Therapeutics (Cytomedix Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Advanced Cell Technology, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioStem Life Sciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akron Biotechnology, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organovo Holdings Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orgenesis Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pluristem Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genzyme
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Athersys, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RenovaCare, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytori Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact